Literature DB >> 24150055

eComment. Transcatheter heart valve in the pulmonary position.

Jamil Hajj-Chahine1.   

Abstract

Mesh：

Year:  2013        PMID： 24150055      PMCID： PMC3805228          DOI： 10.1093/icvts/ivt404

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  5 in total

1.  Short-term performance of the transcatheter Melody valve in high-pressure hemodynamic environments in the pulmonary and systemic circulations.

Authors:  Babar S Hasan; Doff B McElhinney; David W Brown; John P Cheatham; Julie A Vincent; William E Hellenbrand; Thomas K Jones; Evan M Zahn; James E Lock
Journal:  Circ Cardiovasc Interv       Date:  2011-11-09       Impact factor: 6.546

2.  Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial.

Authors:  Damien Kenny; Ziyad M Hijazi; Saibal Kar; John Rhodes; Michael Mullen; Raj Makkar; Girish Shirali; Mark Fogel; John Fahey; Mary G Heitschmidt; Christopher Cain
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

3.  Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial.

Authors:  Evan M Zahn; William E Hellenbrand; James E Lock; Doff B McElhinney
Journal:  J Am Coll Cardiol       Date:  2009-10-27       Impact factor: 24.094

Review 4.  Which is the best tissue valve used in the pulmonary position, late after previous repair of tetralogy of Fallot?

Authors:  Jonathan Raihan Abbas; J Andreas Hoschtitzky
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-08

5.  Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts.

Authors:  Younes Boudjemline; Georgia Brugada; Isabelle Van-Aerschot; Mehul Patel; Adeline Basquin; Caroline Bonnet; Antoine Legendre; Damien Bonnet; Laurence Iserin
Journal:  Arch Cardiovasc Dis       Date:  2012-07-17       Impact factor: 2.340
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.